Posted by Michael Wonder on 11 Jul 2024
FTC to sue drug managers over insulin prices
10 July 2024 - Antitrust agency is investigating how PBMs and manufacturers negotiate discounts.
The Federal Trade Commission is preparing to sue the largest three pharmacy benefit managers over their tactics for negotiating prices for drugs including insulin, after a two-year investigation into whether the companies steer patients away from less-expensive medicines.
